Anupam Rasayan India: Submission of Press Release titled Anupam Rasayan concludes acquisition of Bliss GVS Pharma, makes third…
Anupam Rasayan India (ANURAS) filed a disclosure titled "Submission of Press Release titled Anupam Rasayan concludes acquisition of Bliss GVS Pharma, makes third strategic step towards building an Integrated Global Pharma Platform". The company is valued at…
What happened
Anupam Rasayan India (ANURAS) filed a disclosure with the exchanges on 28 September 2026 at 07:53 PM titled "Submission of Press Release titled Anupam Rasayan concludes acquisition of Bliss GVS Pharma, makes third strategic step towards building an Integrated Global Pharma Platform".
Company snapshot
Anupam Rasayan India is a small-cap company in the Chemicals sector, with a market value of about ₹13,515 crore.
The stock last traded at ₹1,187.1, against a 52-week range of ₹1,047.9–₹1,415 (16.1% below the high).
Before this filing the shares had moved −5.3% over the month and −5.7% over three months. Average daily turnover over the last 20 sessions was about ₹68.17 crore.
Promoters held 59.07% at the end of Q1 FY27; 21.79% of promoter shares were pledged. Foreign institutions owned 7.71% and domestic institutions 0.38%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 486 | 34 | 3.1 |
| Q2 FY26 | 731 | 44.4 | 3.93 |
| Q3 FY26 | 512 | 49 | 4.31 |
| Q4 FY26 | 636 | 42.7 | 3.75 |
| Q1 FY27 | 655 | 38.6 | 3.39 |
What history shows
This is not the company's first m&a disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Across 48 similar disclosures by other Chemicals companies, shares moved −1.2% on average the next day and −1.1% over five days; 31% of them rose the next day.
Market-wide, 1,921 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 50% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
- Anupam Rasayan India Share Price - Live NSE: ANURAS Stock Price & Chart
- Anupam Rasayan share price falls 5% after NCD issue announcement | NCD size, other details here
- Anupam Rasayan files draft offer for Bliss GVS
- Volumes soar at Anupam Rasayan India Ltd counter
- Anupam Rasayan India Stock Signals to Watch This Week
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.